These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 14633719

  • 1. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
    Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH, Saporta S, Boulware D, Moscinski L, Alsina M, Dalton WS.
    Cancer Res; 2003 Nov 15; 63(22):7900-6. PubMed ID: 14633719
    [Abstract] [Full Text] [Related]

  • 2. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells.
    Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM, Dalton WS.
    Cancer Res; 2006 Feb 15; 66(4):2338-45. PubMed ID: 16489039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
    Raje N, Kumar S, Hideshima T, Ishitsuka K, Yasui H, Chhetri S, Vallet S, Vonescu E, Shiraishi N, Kiziltepe T, Elford HL, Munshi NC, Anderson KC.
    Br J Haematol; 2006 Oct 15; 135(1):52-61. PubMed ID: 16925573
    [Abstract] [Full Text] [Related]

  • 6. HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.
    Nimmanapalli R, Gerbino E, Dalton WS, Gandhi V, Alsina M.
    Br J Haematol; 2008 Aug 15; 142(4):551-61. PubMed ID: 18503584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.
    Maiso P, Carvajal-Vergara X, Ocio EM, López-Pérez R, Mateo G, Gutiérrez N, Atadja P, Pandiella A, San Miguel JF.
    Cancer Res; 2006 Jun 01; 66(11):5781-9. PubMed ID: 16740717
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of a melphalan-resistant human multiple myeloma cell line.
    Bellamy WT, Dalton WS, Gleason MC, Grogan TM, Trent JM.
    Cancer Res; 1991 Feb 01; 51(3):995-1002. PubMed ID: 1988143
    [Abstract] [Full Text] [Related]

  • 16. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R.
    Xiao H, Xiao Q, Zhang K, Zuo X, Shrestha UK.
    Ann Hematol; 2010 Apr 01; 89(4):399-404. PubMed ID: 19756599
    [Abstract] [Full Text] [Related]

  • 17. [Reversal of multidrug resistance of the drug resistant human multiple myeloma cell line MOLP-2/R by curcumin and its relation with FA/BRCA pathway].
    Xiao H, Zhang KJ, Zuo XL.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan 01; 30(1):33-7. PubMed ID: 19563033
    [Abstract] [Full Text] [Related]

  • 18. Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas.
    Heikaus S, Casliskan E, Mahotka C, Gabbert HE, Ramp U.
    Apoptosis; 2007 Sep 01; 12(9):1645-57. PubMed ID: 17610067
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.
    Inoue J, Otsuki T, Hirasawa A, Imoto I, Matsuo Y, Shimizu S, Taniwaki M, Inazawa J.
    Am J Pathol; 2004 Jul 01; 165(1):71-81. PubMed ID: 15215163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.